FDA Inspection 762262 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 1000137396

The FDA completed an inspection of New York Blood Center Enterprises on January 6, 2012 in Ronkonkoma, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 6, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ronkonkoma, NY (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs